Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rutan 0.1 in hospitalized COVID-19 patients
NCT05859919Phase 2Completed
- Sponsor
- Research Institute of Virology, Ministry of Health of Uzbekistan
- Start
- Oct 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rutan in coronavirus disease 2019 (COVID-19), sponsored by Research Institute of Virology, Ministry of Health of Uzbekistan. Started Oct 2020; status: completed.
02
Drugs
Rutan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05859919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05859919.